These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27382614)

  • 1. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.
    Ezzati M; Abdullah A; Shariftabrizi A; Hou J; Kopf M; Stedman JK; Samuelson R; Shahabi S
    Int Sch Res Notices; 2014; 2014():953509. PubMed ID: 27382614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
    Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic immunologic signatures in epithelial ovarian cancer.
    James NE; Woodman M; Ribeiro JR
    Oncogene; 2022 Mar; 41(10):1389-1396. PubMed ID: 35031772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Fallopian Tubes in the Development of Ovarian Cancer.
    Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
    J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
    Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
    J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database.
    Hussain I; Xu J; Deng K; Noor-Ul-Amin ; Wang C; Huang Y; Li S; Li K
    J Cancer; 2020; 11(16):4861-4869. PubMed ID: 32626533
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival.
    Engqvist H; Parris TZ; Rönnerman EW; Söderberg EMV; Biermann J; Mateoiu C; Sundfeldt K; Kovács A; Karlsson P; Helou K
    Oncotarget; 2018 Oct; 9(80):35162-35180. PubMed ID: 30416686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes.
    Connor JP; O'Shea A; McCool K; Sampene E; Barroilhet LM
    Gynecol Oncol; 2018 Nov; 151(2):294-298. PubMed ID: 30201233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinicopathologic Characteristics and 5-year Survival Rate of Epithelial Ovarian Cancer in Yazd, Iran.
    Karimi-Zarchi M; Mortazavizadeh SM; Bashardust N; Zakerian N; Zaidabadi M; Yazdian-Anari P; Teimoori S
    Electron Physician; 2015 Oct; 7(6):1399-406. PubMed ID: 26516450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and Who Should Perform Epithelial Ovarian Cancer Surgery?
    Escayola C; Torrent JJ; Ferron G; Quenet F; Querleu D
    Int J Gynecol Cancer; 2018 Mar; 28(3):594-599. PubMed ID: 29303937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
    Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian epithelial carcinoma--a malignant disease sparing no age group].
    Mandić A; Nincić D; Vujkov T
    Med Pregl; 2003; 56(3-4):157-61. PubMed ID: 12899081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.
    Warren JL; Harlan LC; Trimble EL; Stevens J; Grimes M; Cronin KA
    Gynecol Oncol; 2017 Jun; 145(3):486-492. PubMed ID: 28372872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.